You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adult CML

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Concomitant Medications at CML Diagnosis

Completed
  • Chronic Myeloid Leukemia
  • the prevalence of comorbid conditions
  • (no location specified)
Sep 16, 2023

Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • +3 more
  • Augusta, Georgia
  • +1 more
Jul 14, 2022

3rd Line Therapy or More to Treat Adult CML- CP in Real World

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Oct 16, 2023

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

Not yet recruiting
  • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
  • (no location specified)
Jul 11, 2022

Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated

Completed
  • Chronic Myeloid Leukaemia
  • Rionero in Vulture, Potenza, Italy
  • +32 more
Oct 24, 2022

Chronic Myeloid Leukemia Trial in Germany (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Mannheim, Baden-Wuerttemberg, Germany
  • +69 more
Mar 21, 2022

Myeloid Leukemia, Philadelphia Positive Trial in Worldwide (Asciminib Pediatric formulation group, Asciminib Adult formulation

Recruiting
  • Myeloid Leukemia, Philadelphia Positive
  • Asciminib Pediatric formulation group
  • Asciminib Adult formulation group
  • Boston, Massachusetts
  • +24 more
Jan 17, 2023

Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in France (Ponatinib, Imatinib)

Recruiting
  • Philadelphia Chromosome Positive CML
  • BCR-ABL Positive Chronic Myelogenous Leukemia
  • Amiens, France
  • +27 more
Dec 9, 2021

Chronic Myelogenous Leukemia - Chronic Phase Trial in United States (Nilotinib)

Terminated
Has Results
  • Chronic Myelogenous Leukemia - Chronic Phase
  • Los Angeles, California
  • +10 more
Jul 26, 2021

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Trial in Tokyo (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
  • Tokyo, Japan
    Novartis Investigative Site
Dec 6, 2020

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Aichi (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia
  • Aichi, Japan
    Novartis Investigative Site
Dec 6, 2020

Chronic Myeloid Leukemia in Chronic Phase Trial in Belgium, Germany (LBH589)

Terminated
Has Results
  • Chronic Myeloid Leukemia in Chronic Phase
  • Bruxelles, Belgium
  • +9 more
Jul 14, 2021

Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +18 more
Jan 19, 2023

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

Recruiting
  • Acute Biphenotypic Leukemia
  • +13 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Conception/Pregnancy in Adult CML Treated With Tyrosine Kinase

Recruiting
  • Chronic Myeloid Leukemia
  • Pregnancy
    • Rossano, Cosenza, Italy
    • +51 more
    Jan 4, 2022

    According to Molecular Identification at Diagnosis

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Next Generation Sequencing (DNA and RNA)
    • (no location specified)
    Oct 28, 2022

    Chronic Myelogenous Leukemia Trial in Turkey (Nilotinib)

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • Eskisehir, Meselik, Turkey
    • +12 more
    Aug 18, 2020

    Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

    Recruiting
    • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
    • Longmont, Colorado
    • +128 more
    Aug 1, 2022

    Chronic Myelogenous Leukemia Trial in Worldwide (ABL001 40mg BID, ABL001 80mg QD, ABL001 200mg QD)

    Recruiting
    • Chronic Myelogenous Leukemia
    • ABL001 40mg BID
    • +2 more
    • Caba, Buenos Aires, Argentina
    • +53 more
    Jan 27, 2023

    Study Conducted Among Patients With CML

    Completed
    • Chronic Myeloid Leukemia
    • Tyrosine Kinase Inhibitors (TKIs)
    • East Hanover, New Jersey
      Novartis Investigative Site
    Jul 25, 2022

    Recurrent Adult Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Houston (BP1001, BP1001

    Completed
    • Recurrent Adult Acute Myeloid Leukemia
    • +3 more
    • BP1001
    • BP1001 in combination with LDAC
    • Houston, Texas
      M. D. Anderson Cancer Center
    May 26, 2020

    Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

    Withdrawn
    • Drug/Agent Toxicity by Tissue/Organ
    • +3 more
    • amifostine trihydrate
    • +2 more
    • Chicago, Illinois
    • +3 more
    Jan 31, 2023

    CML Trial in Brussels (200 Mg capsules of bosutinib in Water solution, bosunitib sorbitol, Bosutinib Mannitol)

    Completed
    • CML
    • 200 Mg capsules of bosutinib in Water solution
    • +13 more
    • Brussels, Belgium
      Pfizer Clinical Research Unit
    Jul 8, 2020

    Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

    Recruiting
    • Chronic Myelogenous Leukemia - Chronic Phase
    • Birmingham, Alabama
    • +25 more
    Jan 10, 2023

    Myeloid Leukemia, Chronic Trial in Germany (dasatinib (SPRYCEL®))

    Active, not recruiting
    • Myeloid Leukemia, Chronic
    • dasatinib (SPRYCEL®)
    • Aachen, Germany
    • +52 more
    Jun 1, 2022